The Department of Health and Human Services (HHS) is spotlighting the oversight of prescription drug advertising in a year when the US FDA's Office of Prescription Drug Promotion (OPDP) could set a record low for enforcement letters issued.
A May 30 HHS blog post features a video with Mike Sauers, a staff supervisor for OPDP's advertising and promotion policy staff, highlighting his role in co-creating FDA's Bad Ad program
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?